Sorafenib maintenance therapy after allogenic stem cell transplantation reduces relapse rate in FLT3-ITD acute myeloid leukemia
1. Sorafenib maintenance therapy following allogenic stem cell transplantation in FLT3-ITD acute myeloid leukemia was associated with significantly lower rates ...